Akso Health Group (AHG) Balance Sheet

As of 2026-03-31 (20-F), Akso Health Group (AHG) reported total assets of $189.6M, total liabilities of $8.7M and shareholders' equity of $180.9M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $170572.

Source: SEC EDGAR filings · read by EquiReason

AHGAkso Health GroupFollow AHG — free

Specialty Business Services · Industrials

—

Price chart with a free account

Market cap: 1.1B
P/E TTM: —
Dividend yield: —
52-week: —
Next earnings: —

Line	FY2017 Mar 17	FY2018 Mar 18	FY2019 Mar 19	FY2020 Mar 20	FY2021 Mar 21	FY2022 Mar 22	FY2023 Mar 23	FY2024 Mar 24	FY2025 Mar 25	FY2026 Mar 26	Latest Mar 26
Cash and equivalents	19.2	132.6	57.4	6.7	15.1	18.4	7.9	85.2	176.2	0.2	0.2
Receivables	—	0.0	0.1	23.6	8.9	20.0	7.7	—	1.0	1.3	1.3
Inventory	—	—	—	—	—	7.8	1.7	0.2	0.2	0.2	0.2
Current assets	—	163.1	97.7	52.0	30.1	62.8	20.5	142.0	196.1	189.5	189.5
Total assets	28.4	163.9	173.3	80.5	50.7	62.8	20.5	142.0	215.0	189.6	189.6
Current liabilities	—	23.8	26.6	12.4	14.4	50.5	11.6	3.6	13.8	8.7	8.7
Long-term debt	—	—	20.0	20.0	—	—	—	—	—	—	—
Total liabilities	4.9	23.8	46.8	32.4	14.4	50.5	11.6	3.6	15.8	8.7	8.7
Shareholders' equity	23.5	140.0	126.5	48.1	17.3	12.3	8.7	138.4	199.1	180.9	180.9

USD millions · SEC XBRL

Akso Health Group — questions

How much cash does Akso Health Group have?: $170572 in cash and cash equivalents as of 2026-03-31.
What are Akso Health Group's total assets?: $189.6M as of 2026-03-31.
What is Akso Health Group's shareholders' equity?: $180.9M as of 2026-03-31.

Every figure on this page comes from Akso Health Group's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.